Back

Sorium engages with pioneers who are making new markets in their industries. — as strategic advisor, board member or angel.

Waymark

Waymark is the AI video advertising platform that makes broadcast-quality commercials accessible to any small or mid-sized business. Its platform powers media companies, broadcasters, and ad networks like Spectrum Reach and Fox TV stations to offer turnkey video creative directly to local advertisers, replacing the production bottleneck that has historically kept SMBs off TV and CTV. With over one million videos created and a 97%+ completion rate, Waymark is infrastructure for the next wave of local ad spend.  Status: Strategic Advisor / Board Chair

Qtrac

Qtrac is transforming the in-person customer experience for retail, government, healthcare, and financial services. It's cloud-based. Qtrac converts idle wait time into an engagement and marketing channel while delivering real-time operational data to staff and management. Built on 40+ years of physical queuing expertise from parent company Lavi Industries, Qtrac has documented improvements of up to 35% in operational efficiency and 105% in customer satisfaction scores. Status: Strategic Advisor / Board Vice-Chair

Brandlight

The AI Visibility Operating System (OS) and enterprise platform that helps Fortune 500 brands manage and optimize their digital presence across generative search engines, AI platforms, and agentic commerce. It acts as infrastructure to track how LLMs synthesize information, monitor brand mentions, and drive revenue. Status: Advisor / Investor

ARI Science

ARIScience is an AI-accelerated drug discovery company built around a proprietary AI+QQ platform — combining artificial intelligence with quasi-quantum chemistry to design and optimize small-molecule therapeutics with a speed and precision that classical methods can't match. The platform targets some of medicine's hardest problems: neurodegenerative, inflammatory, infectious, and metastatic diseases, with therapeutic candidates in active preclinical development. Status: Strategic Advisor

Airspace Data

The dynamic airspace-sharing platform that helps the FAA, the U.S. military, and commercial airlines coordinate access to restricted airspace in real time. It replaces a decades-old, phone-call-based handoff process with a patented, automated system that tracks airspace status, eliminates manual bottlenecks, and unlocks shorter flight paths. Status: Advisor / Investor

Espalier

Espalier is an enterprise AI platform that turns web-scale market intelligence into actionable revenue signal — helping commercial and strategy teams identify, prioritize, and act on growth opportunities faster than traditional research methods allow. Its continuously evolving knowledge graph fuses external market data, company and people signals, and proprietary enterprise inputs to surface the prospects, M&A targets, and competitive dynamics that matter most.  Status: Partner

EnRevo Pyro

A waste-to-energy platform company that designs, builds, and operates fast-pyrolysis and biomass-gasification systems for municipal, agricultural, commercial, and industrial customers. It turns waste and other feedstock — including hazardous waste other methods can't cleanly process — into power, fuel, and heat, deployable from utility-scale (5MW+) installations down to on-site systems for single facilities. Status: Advisor / Investor

Taurus Technologies

The patented zero-backlash, zero-back-EMF motor technology powering next-generation aerospace propulsion and motion control. Its proprietary electric motors, gearing, and magnetic bearings replace conventional drive systems with ultra-efficient, high-torque designs that cut fuel consumption, maintenance costs, and system weight. Status: Investor

Medlab Group

A Biotechnology company built around NanoCelle®, a patented nanoparticle drug delivery platform that dramatically improves bioavailability by bypassing conventional absorption limitations for pharmaceuticals, nutraceuticals, and cannabinoids. Where traditional oral and injectable formulations lose efficacy to first-pass metabolism, NanoCelle delivers superior dose precision and faster onset at meaningfully lower doses — across a wide range of molecules and market applications. Status: Investor